Status
Conditions
Treatments
About
To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.
Secondary objectives:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
770 participants in 2 patient groups
Loading...
Central trial contact
Soeren Becker, MD, PhD; Cihan Papan, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal